Literature DB >> 22771210

Highly pathogenic porcine reproductive and respiratory syndrome virus GP5 B antigenic region is not a neutralizing antigenic region.

Chao-Liang Leng1, Tong-Qing An, Jia-Zeng Chen, Da-Qing Gong, Jin-Mei Peng, Yong-Qian Yang, Jiang Wu, Juan-Juan Guo, Deng-Yun Li, Yi Zhang, Zhen-Xiang Meng, Yu-Quan Wu, Zhi-Jun Tian, Guang-Zhi Tong.   

Abstract

In 2006, highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) caused great economic losses emerged in China and continues to be a threat for the pig industry. B antigenic region (AR) ((37)SHL/FQLIYNL(45)) of GP5 was considered to be a major linear neutralizing AR in PRRSV classical strains. However, peptide-purified antibodies against this AR did not neutralize PRRSV in a recent report. Compared with classical PRRSV, one amino acid mutation (L/F(39)→ I(39)) was found in B AR of HP-PRRSV. To study the ability of B AR of HP-PRRSV to induce neutralizing antibody (NA) in vitro and in vivo, rabbit antisera against B AR with and without the mutation and pig hyperimmune sera with high titer of NAs against HP-PRRSV were prepared. Immunofluorescence assays (IFA) showed that the two rabbit antisera both had reactivity to classical PRRSV CH-1a and HP-PRRSV HuN4 with no observable difference in IFA titer. However, antisera did not have neutralizing activity against classical PRRSV CH-1a and HP-PRRSV HuN4. No correlation was observed between the levels of anti-B AR peptide antibodies and NAs in pig hyperimmune sera that were detected by indirect ELISA and virus neutralization, respectively. B AR peptide-specific serum antibodies had no neutralizing activity and, GST-B fusion protein could not inhibit neutralization of NAs in pig hyperimmune sera. Based on these findings, we conclude that B AR of HP-PRRSV is not a neutralizing AR of HP-PRRSV GP5.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771210     DOI: 10.1016/j.vetmic.2012.06.018

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

1.  Immunopotentiation of four natural adjuvants co-administered with a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit.

Authors:  Jun Peng; Yanmei Yuan; Si Shen; Zhongxiang Niu; Yijun Du; Jiaqiang Wu; Jun Li; Jiang Yu; Tao Wang; Jinbao Wang
Journal:  Virus Genes       Date:  2016-02-08       Impact factor: 2.332

2.  Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Ambika Mosale Venkatesh Murthy; Yanyan Ni; Xiangjin Meng; Chenming Zhang
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

3.  Unique epitopes recognized by monoclonal antibodies against HP-PRRSV: deep understanding of antigenic structure and virus-antibody interaction.

Authors:  Qian Wang; Jinmei Peng; Yan Sun; Jiazeng Chen; Tongqing An; Chaoliang Leng; Lin Li; Hongyuan Zhao; Xin Guo; Xinna Ge; Hanchun Yang; Zhijun Tian
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  ORF1a of highly pathogenic PRRS attenuated vaccine virus plays a key role in neutralizing antibody induction in piglets and virus neutralization in vitro.

Authors:  Chaoliang Leng; Wuchao Zhang; Hongliang Zhang; Yunchao Kan; Lunguang Yao; Hongyue Zhai; Mingliang Li; Zhen Li; Chunxiao Liu; Tongqing An; Jinmei Peng; Qian Wang; Yumin Leng; Xuehui Cai; Zhijun Tian; Guangzhi Tong
Journal:  Virol J       Date:  2017-08-22       Impact factor: 4.099

5.  Emergence of Two different recombinant PRRSV strains with low neutralizing antibody susceptibility in China.

Authors:  Guangwei Han; Huiling Xu; Kexiong Wang; Fang He
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

6.  Efficacy of Type 2 PRRSV vaccine against challenge with the Chinese lineage 1 (NADC30-like) PRRSVs in pigs.

Authors:  Chunhua Wei; Ailing Dai; Jialin Fan; Yan Li; Anni Chen; Xia Zhou; Manlin Luo; Xiaoyan Yang; Jiankui Liu
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

7.  Efficacy of the Synergy Between Live-Attenuated and Inactivated PRRSV Vaccines Against a NADC30-Like Strain of Porcine Reproductive and Respiratory Syndrome Virus in 4-Week Piglets.

Authors:  Chaosi Li; Zhicheng Liu; Kai Chen; Jie Qian; Yulong Hu; Shuhe Fang; Zhi Sun; Chunhong Zhang; Lv Huang; Jianfeng Zhang; Nian Huang
Journal:  Front Vet Sci       Date:  2022-02-02

8.  Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.

Authors:  Jordan E Young; Cheryl M T Dvorak; Simon P Graham; Michael P Murtaugh
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

Review 9.  Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Authors:  Yuchen Nan; Chunyan Wu; Guoqian Gu; Weiyao Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.